Related Experiment Videos
Exacerbations of chronic obstructive pulmonary disease
Jadwiga A Wedzicha1, Gavin C Donaldson
1Academic Unit of Respiratory Medicine, St Bartholomew's and Royal London School of Medicine and Dentistry, Dominion House, St Bartholomew's Hospital, London EC1A 7BE, United Kingdom. j.a.wedzicha@qmul.ac.uk.
Respiratory Care
|December 4, 2003
Summary
Frequent exacerbations in chronic obstructive pulmonary disease (COPD) significantly impact quality of life. Early therapy for colds and precautions against triggers are vital for managing COPD exacerbations and improving patient outcomes.
Area of Science:
- Pulmonary Medicine
- Infectious Disease
- Epidemiology
Background:
- Exacerbations of chronic obstructive pulmonary disease (COPD) are major contributors to morbidity, hospitalizations, and mortality, profoundly affecting health-related quality of life.
- Frequent exacerbations are linked to significant physiological deterioration and increased airway inflammation, with bacterial and viral infections being primary triggers.
- COPD exacerbations are more common than previously thought, often underreported by patients, and influenced by factors like air pollution and bacterial colonization.
Purpose of the Study:
- To investigate the triggers, characteristics, and patient reporting of chronic obstructive pulmonary disease (COPD) exacerbations.
- To understand the relationship between exacerbation frequency, disease severity, and physiological changes in COPD patients.
- To evaluate the impact of exacerbations on quality of life and explore potential management strategies.
Main Methods:
- Analysis of patient-reported data, including diary cards, to capture exacerbation events.
- Assessment of physiological changes (e.g., peak flow, FEV1) during exacerbation prodromes and recovery.
- Evaluation of factors such as bacterial colonization, sputum biomarkers (e.g., interleukin-8), and treatment efficacy (corticosteroids, antibiotics).
Main Results:
- Approximately half of COPD exacerbations are triggered by infections (viral and bacterial) or air pollution, and many are underreported by patients.
- Physiological changes at exacerbation onset are often minor, but larger decreases in peak flow correlate with dyspnea and viral infections.
- Incomplete physiological recovery post-exacerbation reduces quality of life and increases susceptibility to future events; bacterial colonization is linked to COPD severity and faster FEV1 decline.
Conclusions:
- Identifying patients prone to frequent exacerbations and implementing preventive measures against triggers like colds is crucial.
- Early therapeutic interventions, including short courses of oral corticosteroids and antibiotics, show efficacy in managing exacerbations and potentially delaying subsequent events.
- Progressive airflow obstruction increases exacerbation frequency, highlighting the vulnerability of patients with chronic respiratory failure.